Pfizer withdraws sickle-cell disease treatment | Reuters
WEB4 days ago · Sept 26 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all …
Pfizer pulls sickle cell drug oxbryta, raising safety concerns - BizNews
WEB17 hours ago · Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community. Concerns over its safety, flagged by …
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease …
WEB5 days ago · Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this …
Pfizer withdraws sickle cell treatment due to safety …
WEB3 days ago · Pfizer has voluntarily withdrawn its sickle cell disease treatment Oxbryta (voxelotor) from the market due to safety concerns. The Food and Drug Administration (FDA) recommends clinicians stop …
Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety ...
WEB3 days ago · Pfizer (PFE) shares declined Thursday after the drug maker recalled all lots of its sickle cell disease medicine worldwide because of concerns it could lead to severe …
Pfizer withdraws sickle cell disease treatment on risk of …
WEB4 days ago · (Reuters) -U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks …
Pfizer pulls sickle cell disease therapy Oxbryta from markets
WEB4 days ago · Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 billion acquisition the New York pharma …
Pfizer Sickle Cell Drug Suspended by Europe in New Setback
WEB4 days ago · Oxbryta later received approval in Europe. When Pfizer acquired Global Blood Therapeutics in 2022, it said that Oxbryta and other sickle cell drugs under …
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease
WEB4 days ago · NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that it is voluntarily withdrawing all lots of OXBRYTA® (voxelotor) for the treatment of …
EU Regulator Recommends Suspension of Pfizer's …
WEB4 days ago · REUTERS/Dado Ruvic/Illustration/File Photo. (Reuters) - The European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer's sickle cell disease drug Oxbryta on ...
